rs80338842

chr11-112086910-G-Achr11-112086910-G-C

Variant summary

Our verdict is Pathogenic. Variant got 20 ACMG points: 20P and 0B. PVS1 PS1_Moderate PM2 PP5_Very_Strong

The NM_003002.4(SDHD):c.3G>A(p.Met1?) variant causes a start lost change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).

• Frequency: Genomes: not found (cov: 32)
• Consequence: SDHD NM_003002.4 start_lost
• Clinical Significance: Pathogenic criteria provided, multiple submitters, no conflicts P:2
• Conservation: PhyloP100: 5.01

Genes affected

SDHD (HGNC:10683): (succinate dehydrogenase complex subunit D) This gene encodes a member of complex II of the respiratory chain, which is responsible for the oxidation of succinate. The encoded protein is one of two integral membrane proteins anchoring the complex to the matrix side of the mitochondrial inner membrane. Mutations in this gene are associated with the formation of tumors, including hereditary paraganglioma. Transmission of disease occurs almost exclusively through the paternal allele, suggesting that this locus may be maternally imprinted. There are pseudogenes for this gene on chromosomes 1, 2, 3, 7, and 18. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2013]

ACMG classification

Verdict is Pathogenic. Variant got 20 ACMG points.

• PVS1: Start lost variant, no new inframe start found.
• PS1: Another start lost variant in NM_003002.4 (SDHD) was described as [Pathogenic] in ClinVar as 6906
• PM2: Very rare variant in population databases, with high coverage
• PP5: Variant 11-112086910-G-A is Pathogenic according to our data. Variant chr11-112086910-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 579968.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-112086910-G-A is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	UniProt
SDHD	NM_003002.4	c.3G>A	p.Met1?	start_lost	1/4	ENST00000375549.8

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Appris	UniProt
SDHD	ENST00000375549.8	c.3G>A	p.Met1?	start_lost	1/4	1	NM_003002.4	P1

Frequencies

GnomAD3 genomes Cov.: 32

GnomAD4 exome Cov.: 32

GnomAD4 genome Cov.: 32

ClinVar

Significance: Pathogenic

Submissions summary: Pathogenic:2

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

Pheochromocytoma;C1847319:Carney-Stratakis syndrome;C1868633:Paragangliomas with sensorineural hearing loss;CN166604:Cowden syndrome 3 Pathogenic:1

Pathogenic, criteria provided, single submitter

clinical testing

Invitae

Oct 25, 2022

For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 579968). Disruption of the initiator codon has been observed in individual(s) with head and neck paraganglioma (HNPGL) and pheochromocytoma (PCC) (PMID: 11391796, 15066320, 17576205, 19258401, 19351833, 19454582, 21945342, 22241717). This variant is not present in population databases (gnomAD no frequency). This sequence change affects the initiator methionine of the SDHD mRNA. The next in-frame methionine is located at codon 91. -

Hereditary cancer-predisposing syndrome Pathogenic:1

Pathogenic, criteria provided, single submitter

clinical testing

Ambry Genetics

Jan 27, 2020

The p.M1? pathogenic mutation (also known as c.3G>A) is located in coding exon 1 of the SDHD gene and results from a G to A substitution at nucleotide position 3. This alters the methionine residue at the initiation codon. This mutation has been observed in multiple individuals with pheochromocytomas and/or paragangliomas (Cascón A et al. J. Clin. Endocrinol. Metab. 2009 May;94(5):1701-5; Ben Aim L et al. J. Med. Genet. 2019 Aug;56(8):513-520; Ambry Internal Data). In addition to the clinical data presented in the literature, since sequence variations that modify the initiation codon (ATG) are expected to result in either loss of translation initiation, N-terminal truncation, or cause a shift in the mRNA reading frame, this alteration is interpreted as a disease-causing mutation. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_addAF	Pathogenic	0.63	D
BayesDel_noAF	Pathogenic	0.54
Cadd	Pathogenic	28
Dann	Uncertain	0.99
DEOGEN2	Benign	0.36	T;.;.;.;.;.;.
Eigen	Uncertain	0.49
Eigen_PC	Uncertain	0.43
FATHMM_MKL	Uncertain	0.85	D
LIST_S2	Uncertain	0.90	D;D;D;D;D;.;D
M_CAP	Pathogenic	0.94	D
MetaRNN	Pathogenic	0.99	D;D;D;D;D;D;D
MetaSVM	Pathogenic	1.1	D
MutationTaster	Benign	1.0	D;D;D;D;D
PROVEAN	Benign	-1.4	N;.;N;D;N;N;N
REVEL	Pathogenic	0.76
Sift	Pathogenic	0.0	D;.;D;D;D;D;D
Sift4G	Pathogenic	0.0	D;D;D;D;D;D;D
Polyphen		0.99	D;.;.;.;.;.;.
Vest4		0.80
MutPred		0.98		Gain of catalytic residue at M1 (P = 0.0211);Gain of catalytic residue at M1 (P = 0.0211);Gain of catalytic residue at M1 (P = 0.0211);Gain of catalytic residue at M1 (P = 0.0211);Gain of catalytic residue at M1 (P = 0.0211);Gain of catalytic residue at M1 (P = 0.0211);Gain of catalytic residue at M1 (P = 0.0211);
MVP		0.98
ClinPred		1.0	D
GERP RS		5.2
RBP_binding_hub_radar		0.97
RBP_regulation_power_radar		2.8
Varity_R		0.96
gMVP		0.67

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.030		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs80338842; hg19: chr11-111957634;